Here's why the Lynas Corporation Ltd share price has surged 200% in 2017

The $1.1 billion rare earths business, Lynas Corporation Ltd (ASX:LYC), has come back from the brink rallying nearly 200% in 2017.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the $1.1 billion rare earths business Lynas Corporation Ltd (ASX: LYC) have come back from the brink in 2017 rallying nearly 200%.

Lynas share price

LYC share price
Source: Google Finance

The chart above compares Lynas to Iluka Resources Limited (ASX: ILU) and the broader S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) in 2017. As can be seen, it's been a good year for Lynas' owners. Unfortunately, their shares are still a long way off their all-time high.

During 2011, Lynas shares traded over $2.50 but now change hands for 22 cents. Fortunately, that's 110% higher than this time three months ago.

Why Lynas is rallying

Today's share price rise coincides with the release of Lynas' quarterly cashflow and activities report.

In the updates, the company said it was pleased to announce that its operating cash flow came in at a record $88.4 million.

It also reported record revenue of $112 million, up 108% on the prior corresponding period and 48% higher quarter-over-quarter. Production was up while costs were in-line with forecasts and some debt was repaid.

Looking ahead, the company is confident in its ability to strengthen its business, financially and operationally. It is targeting production of 500 tonnes of NdPr per month.

Foolish Takeaway

Unfortunately for long-term shareholders, Lynas has proven to be a 'gonna' company, so it will take some time before it's back in favour with investors.

However, the latest results appear promising, to say the least.

Therefore, although it is not the type of company that I would buy, it will be interesting to see if it can maintain its performance in 2017 and beyond.

Motley Fool contributor Owen Raszkiewicz has no position in any of the stocks mentioned. You can follow Owen on Twitter @OwenRask. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »